LoginSignup
RPR

Royalty Pharma

Stock
Stock
ISIN: GB00BMVP7Y09
Ticker: RPRX
GB00BMVP7Y09
RPRX

Price

Price

CHART BY

Historical dividends and forecast

All dividend data

Royalty Pharma has so far distributed $0.84 in 2024. The next dividend will be paid on 15.03.2025

$0.678

CHART BY

Frequently asked questions

What is Royalty Pharma's market capitalization?

The market capitalization of Royalty Pharma is $11.07B. Market capitalization is a measure of the total market value of a publicly traded company. It is calculated by multiplying the current stock price by the total number of outstanding shares.

What is Royalty Pharma's Price-to-Earnings (P/E) ratio?

The Price-to-Earnings (P/E) ratio (TTM) for Royalty Pharma is 9.75. This ratio helps investors assess whether a stock is overvalued or undervalued compared to its earnings.

What is the Earnings Per Share (EPS) for Royalty Pharma?

Royalty Pharma's Earnings Per Share (EPS) over the trailing twelve months (TTM) is $2.557. EPS indicates the company's profitability on a per-share basis.

What are the analyst ratings and target price for Royalty Pharma's stock?

Currently, 11 analysts cover Royalty Pharma's stock, with a consensus target price of $41.86. Analyst ratings provide insights into the stock's expected performance.

What is Royalty Pharma's revenue over the trailing twelve months?

Over the trailing twelve months, Royalty Pharma reported a revenue of $2.27B.

What is the EBITDA for Royalty Pharma?

Royalty Pharma's Earnings before interest, taxes, depreciation, and amortization (EBITDA) over the trailing twelve months is $1.54B. EBITDA measures the company's overall financial performance.

What is the free cash flow of Royalty Pharma?

Royalty Pharma has a free cash flow of $2.82B. Free cash flow indicates the cash generated after accounting for cash outflows to support operations and capital assets.

How many employees does Royalty Pharma have, and what sector and industry does it belong to?

Royalty Pharma employs approximately 89 people. It operates in the Health Care sector, specifically within the Pharmaceuticals: Major industry.

What is the free float of Royalty Pharma's shares?

The free float of Royalty Pharma is 380.55M. Free float refers to the number of shares available for public trading, excluding restricted shares.

Financials

Market Cap 
$11.07B
EPS (TTM) 
$2.557
Free Float 
380.55M
P/E ratio (TTM) 
9.75
Revenue (TTM) 
$2.27B
EBITDA (TTM) 
$1.54B
Free Cashflow (TTM) 
$2.82B

Pricing

1D span
$24.12$25.00
52W span
$24.05$31.65

Analyst Ratings

The price target is $41.86 and the stock is covered by 11 analysts.

Buy

10

Hold

1

Sell

0

Information

Royalty Pharma Plc provides drug development services. It operates as a funder of innovation across the biopharmaceutical industry, collaborating with innovators from academic institutions, research hospitals and not-for-profits through small and mid-cap biotechnology companies to global pharmaceutical companies. Its portfolio includes royalties, including AbbVie and J&J’s Imbruvica, Astellas and Pfizer’s Xtandi, Biogen’s Tysabri, Gilead’s HIV franchise, Merck’s Januvia, Novartis’ Promacta, Vertex’s Kalydeco, Orkambi, Symdeko and Trikafta, and five development-stage product candidates. The company was founded by Pablo Gerardo Legorreta and Rory B. Riggs in 1996 and is headquartered in New York, NY.

Employees
89
Industries
Pharmaceuticals: Major
Sector
Health Care

Identifier

ISIN
GB00BMVP7Y09
Primary Ticker
RPRX

Knockouts

Join the conversation
Sign upLogin